|
|
|
|
Real-World Utilization of Cabotegravir/Rilpivirine: An Observational Analysis of Adherence and Persistence using a Patient Support Program in Canada, Preliminary Results
|
|
|
HIV Drug Therapy Glasgow; November 10-13, 2024; Glasgow, Scotland
Callahan LaForty,1 Adenike R. Adelakun,2 Ryan Ng,1 Bo Chen,1 Maria Esther Perez Trejo,1 Lidija Latifovic,1 Simbarashe Mhishi,2 Joann K. Ban2
1IQVIA Solutions Inc., Mississauga, Canada; 2GlaxoSmithKline Inc., Mississauga, Canada
|
|
|
|
|
|
|